Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Wins First-Ever Voucher Race With Anti-Malarial Approval

Jul 23 2018

• By Michael McCaughan

The Marathon Running

Related Content

Priority Review Voucher Crash: Spark's Sale To Jazz Lowest Price Since 2014

May 01 2018

GSK Moves Closer To Priority Review Voucher As US Panel Backs Malaria Drug Tafenoquine

Jul 13 2018

Related Companies

GSK plc

Knight Therapeutics, Inc.

Additional Topics

United States Review Pathway Rare Diseases Approvals Regulation BioPharmaceutical

More from Review Pathways

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.